Erickson Scott Stanley

CRO Scott Stanley sells 74,530 shares (35.0% of holdings) at $23.44 after pattern of well-timed exits at CWAN

Scott Stanley, Chief Revenue Officer of Clearwater Analytics, executed 3 separate sales totaling 74,530 shares for $1,747,109.90 on 2026-02-18, reducing his holdings by 35.0% to 138,630 shares post-transaction. His prior 5 trades at CWAN show a consistent timing pattern: 3 of 3 measurable prior sells at this ticker produced negative 90-day returns (-11.4%, -13.2%, -11.9%), indicating the stock declined after he sold. His cross-ticker track record reflects a 71.43% well-timed sell rate across 9 prior transactions with an average 90-day return of -10.8%, suggesting a pattern of selling before declines. The current price of $23.30 is down 4.2% over the past 30 days and down 25.5% from the 52-week high of $31.26, indicating the stock is trading well below its recent peak. Against this backdrop, a substantial reduction in holdings by a revenue-focused executive at a high-growth company (annual revenue growth +61.9%) that remains unprofitable (net income $-10,335,000.00) merits attention to whether his sales reflect observed revenue-execution challenges or market sentiment shifts not yet fully apparent in public disclosures.

CRO Erickson Scott Stanley sold 44,386 shares for $1,069,369.71; 5 of 5 prior CWAN sales were well-timed (90d declines averaged -23.4%).

Erickson Scott Stanley (Chief Revenue Officer) executed 2 separate sales totaling 44,386 shares for $1,069,369.71 on 2026-01-01, reducing his holdings by -37.8% from 117,303 to 72,917 shares. His prior transaction history at CWAN is notably consistent: all 5 prior sales were well-timed, with 90-day returns averaging -23.4%, suggesting his selling pattern has correctly preceded stock declines. The current price of $24.10 aligns closely with the blended transaction price of $24.09, and the stock has gained 11.0% over 30 days and 36.4% over 90 days—context that will determine whether this sale follows his established pattern. Given the material share reduction and the CRO's demonstrated timing accuracy on this ticker, the outcome of the next 90 days will be instructive for evaluating whether the pattern continues.

CRO Scott Stanley sells 120,863 shares for $3.7M at $30.18–$30.80, cutting holdings 93.9%, near 52-week high.

Scott Stanley, Chief Revenue Officer, executed 2 separate sales on 2025-03-03 totaling 120,863 shares for $3,720,351.47 at prices of $30.18 and $30.80 per share. This represents a -93.9% reduction in his holdings, from 128,765 shares to 7,902 shares post-transaction. The transaction occurs near the 52-week high of $32.79 (current price $30.07 is -8.3% from that peak), and follows a recent pattern: Stanley executed 3 additional sells on 2025-02-19 (outcomes not yet measurable). At this same ticker, his measurable prior 2 sales in June 2024 generated +17.8% and +18.7% returns over 90 days, but neither timing was "well-timed" (both were preceded by price declines, meaning he sold after the decline had already occurred). The timing characterization and near-peak pricing warrant attention alongside the company's solid fundamentals: $115.8M quarterly revenue growth of +22.7% annually, a P/E of 15.58, and positive net income of $3.6M.

CRO Erickson Scott Stanley sold 76,256 shares at $30.07 on 2025-02-19 for $2.3M, reducing CWAN holdings to 124,624 shares

Erickson Scott Stanley, Chief Revenue Officer of Clearwater Analytics Holdings, Inc., executed 3 separate sales on 2025-02-19 totaling 76,256 shares at $30.07 for $2,293,071.30, reducing his holdings by 38.0% to 124,624 shares post-transaction. At his prior trades at CWAN (both on 2024-06-07), the subsequent 90-day returns were +17.8% and +18.7%, indicating his prior sells at this ticker were poorly timed (stock rose after he sold). The current stock price of $31.26 is 3.8% above the sale price and up 9.8% over the prior 30 days, consistent with the pattern of positive post-sell price action seen in his prior CWAN sales. The company remains unprofitable despite strong 21.3% annual revenue growth to $115.8M, which may provide context for executive liquidity decisions during a growth phase.